The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured review

BACKGROUND: A continuous subcutaneous infusion (CSCI) is an effective method of multiple drug administration commonly encountered in end of life care when the oral route is compromised. At present, current practice is to limit syringe driver infusion time to a maximum of 24 hours as dictated by avai...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, James, Dickman, Andrew, Mason, Stephen, Ellershaw, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851608/
https://www.ncbi.nlm.nih.gov/pubmed/29538455
http://dx.doi.org/10.1371/journal.pone.0194236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851608/
https://www.ncbi.nlm.nih.gov/pubmed/29538455
http://dx.doi.org/10.1371/journal.pone.0194236

Ejemplares similares